ATP861 发表于 2025-3-23 10:00:16

http://reply.papertrans.cn/3/231/23009/23009-11.png

上釉彩 发表于 2025-3-23 15:12:08

Submitted on: 19 January 2003.
Revised on: 09 February 2003.
Accepted on: 25 February 2003.
Neuropsychopharmacology Reports

Interim 发表于 2025-3-23 19:59:54

http://reply.papertrans.cn/3/231/23009/23009-13.png

fatty-acids 发表于 2025-3-23 23:01:06

http://reply.papertrans.cn/3/231/23009/23009-14.png

Resistance 发表于 2025-3-24 05:21:30

http://reply.papertrans.cn/3/231/23009/23009-15.png

CLAIM 发表于 2025-3-24 06:43:35

Submitted on: 07 May 2016.
Revised on: 25 May 2016.
Accepted on: 06 June 2016.
Neuropsychopharmacology Reports

Expostulate 发表于 2025-3-24 11:34:15

http://reply.papertrans.cn/3/231/23009/23009-17.png

Harbor 发表于 2025-3-24 18:44:26

http://reply.papertrans.cn/3/231/23009/23009-18.png

听写 发表于 2025-3-24 22:20:04

Submitted on: 23 December 2021.
Revised on: 20 January 2022.
Accepted on: 11 February 2022.
Neuropsychopharmacology Reports

希望 发表于 2025-3-25 02:16:39

http://reply.papertrans.cn/3/231/23009/23009-20.png
页: 1 [2] 3 4
查看完整版本: ESCI期刊Neuropsychopharmacology Reports 2024/2025影响因子:2.138 (NEUROPSYCHOPHARM REP) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与